Skip to content
healthcare.dev
Get a free key

Anthim

NDC 69604-204, obiltoxaximab, solution, from Elusys Therapeutics, Inc..

Product NDC
69604-204
Status
Listed
Labeler
Elusys Therapeutics, Inc.
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125509
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69604-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OBILTOXAXIMAB100 mg/mL

Pharmacologic classes

Anthrax Protective Antigen-directed Antibody Interactions [MoA]; Anthrax Protective Antigen-directed Antibody [EPC]

Package NDCNDC-11Package
69604-204-02696040204021 VIAL, SINGLE-USE in 1 CARTON (69604-204-02) / 6 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/39ad8799-00a4-4fc8-9852-c0536350c474

Use it

Look up 69604-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69604-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69604-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.